Annual report pursuant to Section 13 and 15(d)

Concentration of Risk

v3.3.1.900
Concentration of Risk
12 Months Ended
Nov. 30, 2015
Risks and Uncertainties [Abstract]  
CONCENTRATION OF RISK
CONCENTRATION OF RISK
Most of the Company’s products are sold to major drug and food chains merchandisers, and wholesale beauty-aids distributors throughout the United States and Canada.
During the fiscal years ended November 30, 2015, 2014 and 2013, certain customers each accounted for more than 5% of the Company’s net sales, as follows:
 
 
 
For the Year Ended November 30,
Customer
 
2015
 
2014
 
2013
Walmart
 
34.6
%
 
47.0
%
 
43.0
%
Walgreens
 
13.4
%
 
6.5
%
 
13.0
%
Target
 
7.2
%
 
*

 
*

CVS
 
5.7
%
 
*

 
*

Foreign Sales
 
13.2
%
 
13.6
%
 
5.0
%

 
*
under 5%

The loss of any one of these customers could have a material adverse effect on the Company’s earnings and financial position.
During the fiscal years November 30, 2015, 2014 and 2013, certain products within the Company’s product lines accounted for more than 10% of the Company’s net sales as follows:
 
 
 
For the Year Ended November 30,
Category
 
2015
 
2014
 
2013
Skin Care
 
51.9
%
 
45.9
%
 
44.8
%
Oral Care
 
34.4
%
 
32.9
%
 
35.3
%
Nail Care
 
*

 
13.8
%
 
14.0
%
* - under 10%